Investors Skeptical as AstraZeneca and Bristol Myers Squibb Consider Massive Merger

By Ed Silverman · STAT News · 2026-08-03

Investors Skeptical as AstraZeneca and Bristol Myers Squibb Consider Massive Merger

STAT News reports that AstraZeneca's stock price dropped following rumors of potential merger discussions with Bristol Myers Squibb. The proposed deal would create a pharmaceutical entity valued at approximately $400 billion. While Bristol shares rose on the news, analysts are qu

STAT News reports that AstraZeneca's stock price dropped following rumors of potential merger discussions with Bristol Myers Squibb. The proposed deal would create a pharmaceutical entity valued at approximately $400 billion. While Bristol shares rose on the news, analysts are qu